METHOTREXAT Teva onco 5000 mg/50ml flac 50 ml
7680479990045
CH-47999
L01BA01
07.16.1.
1 / 3
google
Details
- Product number
- 4799904
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- methotrexatum 5000 mg ut methotrexatum natricum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 50 ml corresp. natrium 506.05 mg.
Articles (1)
Methotrexat Teva Onco 5000 mg/50 ml, Injektions-/Infusionslösung
Injektions-/Infusionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
5000.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
506.05 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 358.50
Specialties list
Yes
Generic
Yes
SL addition date:
01/05/2006
Authorization holder
Teva Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 47999
- Drug name
- Methotrexat Teva Onco, Injektions-/Infusionslösung
- Galenic form
- LSIN
- ATC Code
- L01BA01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 23/10/1987
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- METHOTREXAT Teva onco 5000 mg/50ml flac 50 ml
- Description (DE)
- METHOTREXAT Teva onco 5000 mg/50ml Durchstf 50 ml
- Market launch
- 23/10/1987
- Narcotic (BTM)
- No